21. Morse, M.A., et al., A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP- 1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clinical Cancer Research, 1999. 5(6): p. 1331-8.